News

Conny Skuthälla Managing Director for KWD Nuclear Instruments AB.

February 1, 2023 Hans Engström resigned as Managing Director for KWD Nuclear Instruments AB. Hans has been MD of the company since 2016 and decided now to retire. As the new MD for the company the board has appointed Conny Skuthälla.
(See PDF for futher reading.)


Heliprobe® System
Heliprobe® System is a Urea Breath Test perfectly suited for primary diagnosis and for post treatment follow-up of Helicobacter pylori infection.
It is a reliable, safe and cost-effective near-patient testing system consisting of three components: HeliCap™, BreathCard™ and Heliprobe® Analyzer.
Heliprobe® System is a method with unique advantages:
Convenience – Easy to use, near patient testing, no need to send sample for analysis
Comfort – Painless, no invasive gastroscopic tubing
Speed – Samples are ready for analysis in only 10 minutes with test result available in 5 minutes

Heliprobe® System consists of three components:
Heliprobe®Analyzer
HeliCap™ – 14C-urea capsules (Mayoly Spindler Laboratories)
BreathCard™

We are proud to manufacture the Heliprobe®Analyzer and BreathCard™ to Mayoly / Kibion.
https://lnkd.in/dhaxg_zA
https://lnkd.in/dHMVvNya

KWD Nuclear Instruments AB

Moved to new facilities from June 2022.
New address Wahlströms Väg 24 611 38 Nyköping

KWD Nuclear Instruments AB  Qualified for ISO 9001:2015 and ISO-13485:2016.

KWD Nuclear Instrument AB where in May 2021 qualified for both ISO 13485:2016 and ISO-9001:2015.